Sequence LifeScience, Inc. announced that it has received $5.5 million in funding from NEXGEL, Inc.

Published: 2026-05-06 11:50:51 ET NXGL

Published on 05/06/2026 at 11:50 am EDT

Sequence LifeScience, Inc. announced that it has received $5.5 million in round of funding on May 6, 2026. The transaction included the participation from new investor NEXGEL, Inc. The company issued convertible preferred stock in the transaction.